Patents by Inventor Michael Theisen

Michael Theisen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240148501
    Abstract: A delivery device includes a catheter, and an inflatable balloon coupled to the catheter, the inflatable balloon forming a leading pillow and a trailing pillow spaced from the leading pillow, the leading pillow and the trailing pillow defining a valve seat therebetween to retain a prosthetic heart valve during tracking of the delivery device.
    Type: Application
    Filed: October 31, 2023
    Publication date: May 9, 2024
    Applicant: St. Jude Medical, Cardiology Division, Inc.
    Inventors: Neil Theisen, Michael Shane Morrissey, Tyler Govek, Hannah Thatcher, Hans Rieckmann, Robert Schulzetenberg, Peter J. Ness, Victoria Schuman
  • Publication number: 20240078502
    Abstract: A system, method, and a package tracking device for tracking the movement of a package to prevent theft of the package are described. According to an embodiment, a package tracking device adapted to be attached with a package is described. The package tracking device having a unique device identification number allows a user, through an application interface running of a wireless communication device, to associate a geographical boundary (geo-fencing) with the delivery address of the package. The package tracking device operates in a passive tracking mode when the package is within the defined geographical boundary, generates a first signal when the package is moved from a drop location, generates a second signal when the package is moved out from the geofencing associated with the delivery address and operates in active tracking mode when the package is moved out from the geofencing associated with the delivery address.
    Type: Application
    Filed: March 31, 2023
    Publication date: March 7, 2024
    Inventors: Larry Fox, Derrick Gaderson, Jeff Theisen, Michael Geminden
  • Publication number: 20230241194
    Abstract: Pre-erythrocytic malaria vaccines with good preservation stability and immunostimulatory action are provided. According the present invention, combination use of a pharmaceutical composition comprising (4E,8E,12E,16E,20E)-N-{2-[{4-[(2-amino-4-{[(3S)-1-hydroxyhexan-3-yl]amino}-6-methylpyrimidin-5-yl)methyl]benzyl}(methyl)amino]ethyl}-4,8,12,17,21,25-hexamethylhexacosa-4,8,12,16,20,24-hexaeneamide, or a pharmaceutically acceptable salt thereof, as a vaccine adjuvant with enhanced specific immune response against antigens and good preservation stability and a malaria vaccine with biological activity allow for the provision of pre-erythrocytic malaria vaccines with good preservation stability and immunostimulatory action.
    Type: Application
    Filed: December 1, 2020
    Publication date: August 3, 2023
    Inventors: C. Richter King, Yimin Wu, Jordan Lee Plieskatt, Michael Theisen, Susheel Kumar Singh, Akihisa Fukushima
  • Patent number: 11559721
    Abstract: A cycling device used for exercise and/or rehabilitation includes a shaft for grasping by a user, a foot assembly coupled to the shaft and configured to be supported on a surface, and a pedal assembly coupled between the shaft and the foot assembly. The cycling device is intended to be used by a seated user.
    Type: Grant
    Filed: May 4, 2021
    Date of Patent: January 24, 2023
    Assignee: WhiteBoard Product Solutions
    Inventors: Louis Frederick Polk, Paul Michael Theisen
  • Publication number: 20220355161
    Abstract: A cycling device used for exercise and/or rehabilitation includes a shaft for grasping by a user, a foot assembly coupled to the shaft and configured to be supported on a surface, and a pedal assembly coupled between the shaft and the foot assembly. The cycling device is intended to be used by a seated user.
    Type: Application
    Filed: May 4, 2021
    Publication date: November 10, 2022
    Inventors: Louis Frederick Polk, Paul Michael Theisen
  • Publication number: 20220194996
    Abstract: The present invention relates to a method for recombinant production of a fusion protein comprising multiple malaria antigens for inducing immune responses comprising a combination of antibodies. In particular, the fusion proteins of the present invention comprise fragments of both Pfs230 and Pfs48/45 to lower the required threshold of functional antibodies and to reduce the risk of escape mutations. Thus, the fusion proteins of the present invention are suitable for use in a multivalent malaria vaccine.
    Type: Application
    Filed: March 30, 2020
    Publication date: June 23, 2022
    Inventors: Susheel Kumar Singh, Michael Theisen
  • Publication number: 20190023544
    Abstract: A heavy-duty lift truck designed as a mast-based apparatus comprising a mast, a load accepting means is mounted on the mast in such a way that it can be raised and lowered, and the heavy-duty lift truck is designed at least for a load capacity of 8 tons, with the heavy-duty lift truck comprising a powertrain with a travel drive that comprises an electric drive unit whereby the heavy-duty lift truck has greater energy efficiency.
    Type: Application
    Filed: October 27, 2016
    Publication date: January 24, 2019
    Inventors: Mike Hegewald, Lars Michael Theißen, Heinz Ishorst
  • Patent number: 9793178
    Abstract: The capacity to measure nanoscale features rapidly and accurately is of central importance for the monitoring of manufacturing processes in the production of computer integrated circuits. It is known that far-field scattered light requires a priori sample information in order to reconstruct nanoscale information such as is required in semiconductor metrology. Parameters of interest include, for example, trench depth, duty cycle, wall angle and oxide layer thickness. We describe a scatterometry apparatus and method that uses unconventional polarization states in the pupil of a high NA objective lens, and refer to this as focused beam scatterometry, in which the illumination consists of a focused field with a suitably tailored, spatially-varying polarization distribution. We describe how four or more parameters can be measured and distinguished with an accuracy consistent with the needs laid out in the semiconductor roadmap.
    Type: Grant
    Filed: August 24, 2015
    Date of Patent: October 17, 2017
    Assignee: University of Rochester
    Inventors: Miguel A. Alonso, Stephen Head, Michael Theisen, Thomas Brown
  • Patent number: 9422348
    Abstract: The present invention relates to a method for the production of correctly folded Pfs48/45. This is achieved in the lactococcus lactis when Pfs48/45 or fractions thereof are fused genetically to a glutamate rich protein, e.g. GLURP from Plasmodium falciparum.
    Type: Grant
    Filed: October 3, 2012
    Date of Patent: August 23, 2016
    Inventors: Michael Theisen, Gorm Andersen
  • Publication number: 20160061723
    Abstract: The capacity to measure nanoscale features rapidly and accurately is of central importance for the monitoring of manufacturing processes in the production of computer integrated circuits. It is known that far-field scattered light requires a priori sample information in order to reconstruct nanoscale information such as is required in semiconductor metrology. Parameters of interest include, for example, trench depth, duty cycle, wall angle and oxide layer thickness. We describe a scatterometry apparatus and method that uses unconventional polarization states in the pupil of a high NA objective lens, and refer to this as focused beam scatterometry, in which the illumination consists of a focused field with a suitably tailored, spatially-varying polarization distribution. We describe how four or more parameters can be measured and distinguished with an accuracy consistent with the needs laid out in the semiconductor roadmap.
    Type: Application
    Filed: August 24, 2015
    Publication date: March 3, 2016
    Applicant: UNIVERSITY OF ROCHESTER
    Inventors: Miguel A. Alonso, Stephen Head, Michael Theisen, Thomas Brown
  • Patent number: 8889142
    Abstract: The present invention is related to antigen from Chlamydia trachomatis which are recognized by specific antibodies from individuals infected with Chlamydia or which can induce T cells from the same individuals to secrete gamma-interferon. The T cell reactive antigens are present in a whole-cell lysate and have apparent molecular weights of 5-12, 16-20, 25-35 and 58-74 kDa as determined by SDS-PAGE. The antigens of the invention are believed to be useful in vaccines but also as diagnostic compositions.
    Type: Grant
    Filed: October 11, 2005
    Date of Patent: November 18, 2014
    Assignee: Statens Serum Institut
    Inventors: Michael Theisen, Anja Olsen, Robert Leah, Frank Follmann, Klaus Jensen, Peter Andersen
  • Publication number: 20140170182
    Abstract: The present invention relates to a method for the production of correctly folded Pfs48/45. This is achieved in the lactococcus lactis when Pfs48/45 or fractions thereof are fused genetically to a glutamate rich protein, e.g. GLURP from Plasmodium falciparum.
    Type: Application
    Filed: October 3, 2012
    Publication date: June 19, 2014
    Applicant: STATENS SERUM INSTITUT
    Inventors: Michael Theisen, Gorm Andersen
  • Publication number: 20110020387
    Abstract: A fusion protein, from P. falciparum Glutamate-rich protein (GLURP) genetically coupled to P. falciparum Merozoite surface protein 3 (MSP3) was produced in Lactococcus lactis as a secreted recombinant GLURP-MSP3 hybrid protein and experiments showed that the GLURP-part of the hybrid increased the overall antibody response. Immunizations with the hybrid protein consistently generated a stronger antibody response against the individual GLURP and MSP3 domains than a mixture of the two recombinant molecules injected at one site or the individual recombinant molecules injected simultaneously at two different sites. The difference was most pronounced for the MSP3-specific antibody response suggesting that T cell epitopes located in the GLURP RO-region provide help for B-cell epitopes in the MSP3 region.
    Type: Application
    Filed: June 3, 2010
    Publication date: January 27, 2011
    Applicant: STATENS SERUM INSTITUT
    Inventors: MICHAEL THEISEN, SØREN JEPSEN
  • Patent number: 7749507
    Abstract: A fusion protein, derived from P. falciparum Glutamate-rich protein (GLURP) genetically coupled to P. falciparum Merozoite surface protein 3 (MSP3) was produced in Lactococcus lactis as a secreted recombinant GLURP-MSP3 hybrid protein and experiments showed that the GLURP-part of the hybrid increased the overall antibody response. Immunizations with the hybrid protein consistently generated a stronger antibody response against the individual GLURP and MSP3 domains than a mixture of the two recombinant molecules injected at one site or the individual recombinant molecules injected simultaneously at two different sites. The difference was most pronounced for the MSP3-specific antibody response suggesting that T cell epitopes located in the GLURP RO-region provide help for B-cell epitopes in the MSP3 region.
    Type: Grant
    Filed: May 12, 2005
    Date of Patent: July 6, 2010
    Assignee: Statens Serum Institut
    Inventors: Michael Theisen, Søren Jepsen
  • Publication number: 20090304722
    Abstract: The present invention is related to antigens from Chlamydia trachomatis which are recognized by specific antibodies from individuals infected with Chlamydia or which can induce T cells from the same individuals to secrete gamma-interferon. The T cell reactive antigens are present in a whole-cell lysate and have apparent molecular weights of 5-12, 16-20, 25-35 and 58-74 kDa as determined by SDS-PAGE. The antigens of the invention are useful in vaccines but also as diagnostic compositions.
    Type: Application
    Filed: October 11, 2005
    Publication date: December 10, 2009
    Inventors: Michael Theisen, Anja Olsen, Robert Leah, Frank Follmann, Klaus Jensen, Peter Andersen
  • Publication number: 20060024324
    Abstract: A fusion protein, from P. falciparum Glutamate-rich protein(GLURP) genetically coupled to P. falciparum Merozoite surface protein 3 (MSP3) was produced in Lactococcus lactis as a secreted recombinant GLURP-MSP3 hybrid protein and experiments showed that the GLURP-part of the hybrid increased the overall antibody response. Immunizations with the hybrid protein consistently generated a stronger antibody response against the individual GLURP and MSP3 domains than a mixture of the two recombinant molecules injected at one site or the individual recombinant molecules injected simultaneously at two different sites. The difference was most pronounced for the MSP3-specific antibody response suggesting that T cell epitopes located in the GLURP RO-region provide help for B-cell epitopes in the MSP3 region.
    Type: Application
    Filed: May 12, 2005
    Publication date: February 2, 2006
    Inventors: Michael Theisen, Soren Jepsen
  • Publication number: 20040204294
    Abstract: Exercise apparatus for exercising the upper body simultaneously with lower body exercise, comprising a lower body exercise machine and at least one upper body exercise module positioned for use in conjunction with the lower body exercise machine. The upper body exercise module comprises an elongated connector having first and second ends; a user engagement connected to the elongated connector first end for engaging or being engaged by a body appendage of a user; and a resistance mechanism for resisting a force applied to the first end of the elongated connector. Each upper body exercise module is adapted to provide resistance to a full, natural arm swing of at least one arm of the user. Various types of lower body exercise machines, resistance devices, user engagements, relationships between the upper body exercise module and the lower body exercise machine, and exercise methods using the apparatus are disclosed.
    Type: Application
    Filed: July 1, 2003
    Publication date: October 14, 2004
    Inventors: William T Wilkinson, Paul Michael Theisen, Micah Tobias Somers
  • Publication number: 20040086949
    Abstract: The present invention relates to a method for preparing a ligand presenting assembly (LPA), an LPA, an immunological composition and a vaccine. The invention further relates to a method for generating antibodies, a kit for use in diagnosis and use of an LPA for preparing a pharmaceutical composition.
    Type: Application
    Filed: December 1, 2003
    Publication date: May 6, 2004
    Applicant: Statens Serum Institut
    Inventors: Arne Holm, Rikke Malene Jorgensen, Soren Ostergaard, Michael Theisen
  • Patent number: 6716574
    Abstract: A diagnostic method is disclosed which utilizes short C-terminal fragments of Borrelia burgdorferi sensu lato derived protein OspC. The 4 amino-terminal acids Pro-Lys-Pro (SEQ ID NO: 22) are shown to be essential in immune reactivity between sera from patients suffering from early borreliosis and various OspC derivatives and it is shown that in order to be effective as a diagnostic agent, 5 consecutive amino acid residues long homologue of a fragment identical to the 10 C-terminal amino acids of OspC (SEQ DI NO: 1). Also disclosed are vaccines utilizing the short peptides as well as methods for their preparation.
    Type: Grant
    Filed: October 10, 2001
    Date of Patent: April 6, 2004
    Assignee: Dako A/S
    Inventors: Marianne Jartved Mathiesen, Michael Theisen, Arne Holm, Søren Østergaard
  • Patent number: D740084
    Type: Grant
    Filed: May 20, 2014
    Date of Patent: October 6, 2015
    Assignee: CleanCut Solutions LLC
    Inventors: Anthony L. Schmitt, Michael Theisen